- Home
- HRMY vs OLO Comparison
HRMY vs OLO Comparison
Compare HRMY & OLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- OLO
- Stock Information
- Founded
- HRMY 2017
- OLO 2005
- Country
- HRMY United States
- OLO United States
- Employees
- HRMY N/A
- OLO N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- OLO Major Banks
- Sector
- HRMY Health Care
- OLO Finance
- Exchange
- HRMY Nasdaq
- OLO Nasdaq
- Market Cap
- HRMY 2.1B
- OLO 1.7B
- IPO Year
- HRMY 2020
- OLO 2021
- Fundamental
- Price
- HRMY $35.99
- OLO $10.26
- Analyst Decision
- HRMY Strong Buy
- OLO Buy
- Analyst Count
- HRMY 9
- OLO 3
- Target Price
- HRMY $55.33
- OLO $10.17
- AVG Volume (30 Days)
- HRMY 531.4K
- OLO 4.0M
- Earning Date
- HRMY 10-28-2025
- OLO 08-04-2025
- Dividend Yield
- HRMY N/A
- OLO N/A
- EPS Growth
- HRMY 58.41
- OLO N/A
- EPS
- HRMY 3.10
- OLO N/A
- Revenue
- HRMY $772,527,000.00
- OLO $314,327,000.00
- Revenue This Year
- HRMY $20.09
- OLO $20.82
- Revenue Next Year
- HRMY $16.74
- OLO $17.11
- P/E Ratio
- HRMY $11.61
- OLO N/A
- Revenue Growth
- HRMY 17.74
- OLO 21.92
- 52 Week Low
- HRMY $26.47
- OLO $4.56
- 52 Week High
- HRMY $41.61
- OLO $10.55
- Technical
- Relative Strength Index (RSI)
- HRMY 47.09
- OLO 61.85
- Support Level
- HRMY $36.50
- OLO $10.18
- Resistance Level
- HRMY $38.28
- OLO $10.27
- Average True Range (ATR)
- HRMY 0.95
- OLO 0.02
- MACD
- HRMY -0.17
- OLO -0.02
- Stochastic Oscillator
- HRMY 9.84
- OLO 85.71
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About OLO Olo Inc.
Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.